To sell a dispensary confidentially, prepare reconciled financials and a clean regulatory file first, get a valuation that reflects Section 280E and the license's transferability, market the business anonymously to qualified buyers under NDA, negotiate an LOI structured around the state's change-of-ownership process, and close after regulator approval. Staff, landlords and competitors should learn on your schedule, not from a listing.
Start with what a buyer will reconcile
A cannabis buyer will compare your state track-and-trace reports, POS data, sales and excise tax filings, and federal returns. If they tell four different stories, the deal slows or dies. Reconcile them before anyone sees them.
The first month of a dispensary sale is usually spent on the seller's own records. Every regulated market produces a state-reported sales figure. The buyer will pull it, and they will put it next to your POS export, your sales tax returns and your federal return. Where those diverge, they will assume the worst version is true.
Get ahead of it. Reconcile the four sources monthly for the trailing two years, document the differences you can explain (returns, promotions, timing), and fix the bookkeeping that caused the ones you cannot. This is not glamorous work. It is the work that decides whether the buyer trusts anything else you say.
Value the business the way the buyer will
Dispensary value rests on normalized cash flow after 280E, adjusted for the license's transferability, the lease or property, compliance history and how deep the buyer pool is in your state. Multiples published before the December 2025 rescheduling order should be treated as stale.
Cannabis retail is taxed unlike any other business. Section 280E disallows ordinary deductions for Schedule I trafficking, so after-tax cash flow is lower than a comparable non-cannabis store would produce. As of April 2026, qualifying medical products were placed in Schedule III, but adult-use cannabis remained in Schedule I and fully subject to 280E. A buyer will price the after-tax reality, not the top line.
Then the license. In a capped market with no new entrants, the license carries a premium; in an oversupplied market it does not. Whether it transfers cleanly, whether the buyer can pass background review, whether your social-equity or conditional status restricts a sale: all of these move the range. Consultant-published multiple ranges exist. Use them as context, not as a price.
Know your state's change-of-ownership path before you market
Every state approves new owners differently. Some allow an amendment with continued operations; some require a new application and a pause; some restrict transfers by license class. The path decides your timeline and your deal structure, so confirm it with regulatory counsel before you talk to a buyer.
New York's true-party-of-interest rules, Massachusetts' updated change-of-ownership requirements effective June 2026, New Jersey's ownership caps, Florida's Rule 64-4.018 and California's amendment-versus-new-application distinction are all different answers to the same question. A buyer who has done deals in your state will know the answer. You should know it first.
The path also shapes structure. Where the buyer cannot influence operations before approval, interim arrangements are limited. Where approval can take months, deposits, break fees and covenants have to be written around the wait.
Market it without a listing
A confidential dispensary sale starts with an anonymous teaser sent directly to qualified buyers. Only after an executed NDA, an approval and proof of funds does a buyer receive the CIM. No listing, no marketplace, no 'dispensary for sale' page.
The buyer universe in cannabis is narrow and specific: multi-state operators adding density, regional operators adding a store, well-capitalized single-license owners expanding, and cannabis-focused capital. That is a list you call, not an audience you advertise to. Listing sites exist. They are where confidentiality goes to die.
Management meetings and site visits are scheduled after close or off-site where possible. Staff learn when the deal is under contract and the timing is planned, unless a key manager needs to be brought in under confidentiality earlier.
Negotiate the LOI around the approval gate
A dispensary LOI should set price, structure, deposit, exclusivity, the approval condition, the timeline, and what happens if the regulator says no. Earnouts, seller notes and real-estate carve-outs are common because acquisition financing in cannabis is limited.
Two offers with the same headline price can be worth very different amounts once you model cash at close, the seller note's terms, the earnout's metric and controls, the working capital peg and the treatment of inventory. Model every offer on the same basis before you choose.
If you own the real estate, decide with your tax advisor whether it sells with the business, sells separately to a sale-leaseback investor, or stays with you on a market lease to the buyer. The choice changes price, taxes and who can close.
Close after approval, not before
The definitive agreement is signed subject to regulator approval; closing and the transfer of funds occur after it. Any success fee is paid through the closing process.
Between signing and approval, the seller keeps running the store. Covenants cover what can and cannot change. When approval arrives, the closing checklist executes: consents, funds, transition. Then, and only then, the announcement you control.
